AI Verdict
ENS has stronger fundamentals based on our AI analysis.
ENTA vs ENS Fundamental Comparison
| Metric | ENTA | ENS |
|---|---|---|
| Revenue | $18.6M | $2.8B |
| Net Income | $-11.9M | $216.3M |
| Net Margin | -64.1% | 7.8% |
| ROE | -9.4% | 11.4% |
| ROA | -3.6% | 5.3% |
| Current Ratio | 4.44x | 2.75x |
| Debt/Equity | 0.02x | 0.61x |
| EPS | $-0.42 | $5.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ENTA vs ENS: Frequently Asked Questions
Is ENTA or ENS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ENS has stronger fundamentals. ENTA is rated STRONG SELL (85% confidence) while ENS is rated BUY (75% confidence). This is not investment advice.
How does ENTA compare to ENS fundamentally?
ENANTA PHARMACEUTICALS INC has ROE of -9.4% vs EnerSys's 11.4%. Net margins are -64.1% vs 7.8% respectively.
Which stock pays higher dividends, ENTA or ENS?
ENTA has a dividend yield of N/A or no dividend while ENS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ENTA or ENS for long term?
For long-term investing, consider that ENTA has STRONG SELL rating with 85% confidence, while ENS has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ENTA vs ENS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ENTA vs ENS, the AI consensus favors ENS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.